FOCUS
For hierarchy
STEM CELL THERAPY AND DRUG DISCOVERY
During the past few years, we witnessed explosive progress in the field of stem cell research, leading to an increasing hope for more effective cell replacement therapies to treat various diseases. The self-renewal capability of stem cells, combined with their ability to differentiate into different cell types under programmed conditions, enables improved models for drug discovery and mechanism-based studies of diseases, hence laying the foundation for their therapeutic applications. In fact, induced pluripotent stem cell (iPSC)-based transplantation therapy has already been performed in rodent models.
This special edition of Acta Pharmacologica Sinica on "stem cell therapy and drug discovery" includes 11 articles that highlight both new findings and emerging ideas in different aspects of stem cell technologies, clinical therapies and drug discoveries. The collection of these impressive articles provides an excellent reference map for experts and a point of entry into this exciting research field for the novice.
Original Articles
Identification of a small molecule 1,4-bis-[4-(3-phenoxy-propoxy)-but-2-ynyl]-piperazine as a novel inhibitor of the transcription factor p53
Xin Liu, Ying Zhang, Man Tong, Xiu-ying Liu, Guan-zheng Luo, Dong-fang Xie, Shao-fang Ren, Dong-hui Bai, Liu Wang, Qi Zhou and Xiu-jie Wang
Acta Pharmacologica Sinica 34: 777–783; doi:10.1038/aps.2013.61
Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs
Guan-hua Rao, Hong-min Liu, Bao-wei Li, Jia-jie Hao, Yan-lei Yang, Ming-rong Wang, Xiao-hui Wang, Jun Wang, Hai-jing Jin, Lei Du and Quan Chen
Acta Pharmacologica Sinica 34: 793–804; doi:10.1038/aps.2013.56
Reviews
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
Xiao-hong Xu and Zhong Zhong
Acta Pharmacologica Sinica 34: 755–764; doi:10.1038/aps.2013.63
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Ke Chen, Ying-hui Huang and Ji-long Chen
Acta Pharmacologica Sinica 34: 732–740; doi:10.1038/aps.2013.27